MCLEAN, Va.--(BUSINESS WIRE)--
Driven by its responsibility to protect and promote public health, the
U.S. Food and Drug Administration (FDA) ensures that patients and
providers have timely and continued access to safe, effective, and
high-quality medical products. To advance that mission, in October of
2017, the FDA's Center for Drug Evaluation and Research (CDER) awarded
Booz Allen Hamilton (NYSE: BAH) one of two spots on a competitive, $300
million Blanket Purchase Agreement (BPA) over seven years to support its
implementation of a transformational Informatics Platform that will
enable the Agency to bring life-saving drugs to market with greater
speed and efficiency.
This press release features multimedia. View the full release here:
http://www.businesswire.com/news/home/20180228005966/en/
"We are thrilled to partner with the FDA to deliver leading-edge
informatics and analytics capabilities to expedite the approval of
innovative new products and personalized medicines," said Roman
Salasznyk, Principal at Booz Allen. "Backed by our team of experienced
data scientists and technologists, we will work with CDER to provide its
reviewer community an integrated Platform that will enable the rapid
processing, validation, management, and analysis of data across the
medical product lifecycle. Holistic drug review management is the
future, and we look forward to helping the FDA continue its exceptional
mission performance on behalf of the American public."
Read more about Booz Allen's commitment to helping healthcare and life
sciences organizations across the private and public sectors, here: boozallen.com/markets/health.html.
About Booz Allen Hamilton
For more than 100 years, business, government, and military leaders have
turned to Booz Allen Hamilton to solve their most complex problems. They
trust us to bring together the right minds: those who devote themselves
to the challenge at hand, who speak with relentless candor, and who act
with courage and character. They expect original solutions where there
are no roadmaps. They rely on us because they know that—together—we will
find the answers and change the world.
We solve the most difficult management and technology problems through a
combination of consulting, analytics, digital solutions, engineering,
and cyber expertise. With global headquarters in McLean, Virginia, our
firm employs more than 23,300 people and had revenue of $5.80 billion
for the 12 months ended March 31, 2017. To learn more, visit BoozAllen.com.
(NYSE: BAH)
BAHPR-CW
View source version on businesswire.com: http://www.businesswire.com/news/home/20180228005966/en/
Booz Allen
Media Relations
Joseph Campbell, 703-377-4422
Campbell_Joseph@bah.com
or
Investor
Relations
Curt Riggle, 703-377-5332
Riggle_Curt@bah.com
Source: Booz Allen
News Provided by Acquire Media
